Beverly Khnie Philip, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Postoperative Nausea and Vomiting | 17 | 2021 | 128 | 2.620 |
Why?
|
| Ambulatory Surgical Procedures | 22 | 2016 | 464 | 1.650 |
Why?
|
| Methyl Ethers | 7 | 2001 | 196 | 0.830 |
Why?
|
| Antiemetics | 9 | 2020 | 186 | 0.770 |
Why?
|
| Anesthetics, Inhalation | 7 | 2001 | 574 | 0.570 |
Why?
|
| Consensus | 5 | 2021 | 3122 | 0.480 |
Why?
|
| Anesthesia, General | 7 | 2018 | 1174 | 0.460 |
Why?
|
| Ethers | 4 | 1997 | 73 | 0.450 |
Why?
|
| Anesthetics, Intravenous | 5 | 2001 | 396 | 0.440 |
Why?
|
| Propofol | 4 | 2010 | 603 | 0.390 |
Why?
|
| Anesthesia, Inhalation | 3 | 1997 | 220 | 0.380 |
Why?
|
| Accreditation | 1 | 2014 | 473 | 0.360 |
Why?
|
| Quinolizines | 2 | 2000 | 20 | 0.350 |
Why?
|
| Disease Management | 2 | 2020 | 2504 | 0.350 |
Why?
|
| Anesthesia Recovery Period | 9 | 2001 | 155 | 0.330 |
Why?
|
| Infusions, Intravenous | 8 | 2015 | 2217 | 0.300 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2020 | 370 | 0.300 |
Why?
|
| Ambulatory Care Facilities | 1 | 2014 | 934 | 0.300 |
Why?
|
| Hypnotics and Sedatives | 2 | 2010 | 1178 | 0.280 |
Why?
|
| gamma-Cyclodextrins | 2 | 2016 | 17 | 0.260 |
Why?
|
| Androstanols | 2 | 2016 | 45 | 0.250 |
Why?
|
| Isoflurane | 3 | 1998 | 384 | 0.250 |
Why?
|
| Succinylcholine | 2 | 2016 | 66 | 0.250 |
Why?
|
| Conscious Sedation | 1 | 2010 | 532 | 0.250 |
Why?
|
| Operating Rooms | 3 | 2015 | 790 | 0.250 |
Why?
|
| Alfentanil | 4 | 1999 | 27 | 0.240 |
Why?
|
| Piperidines | 3 | 1999 | 1657 | 0.240 |
Why?
|
| Anesthesia | 4 | 2017 | 1592 | 0.220 |
Why?
|
| Anesthesia, Conduction | 4 | 1996 | 262 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7389 | 0.210 |
Why?
|
| Analgesics, Opioid | 6 | 2021 | 3801 | 0.210 |
Why?
|
| Flumazenil | 2 | 1993 | 84 | 0.200 |
Why?
|
| Ondansetron | 3 | 2007 | 95 | 0.200 |
Why?
|
| Indoles | 2 | 2000 | 1832 | 0.190 |
Why?
|
| Pain, Postoperative | 4 | 2015 | 1737 | 0.180 |
Why?
|
| Midazolam | 3 | 2001 | 266 | 0.180 |
Why?
|
| Infusions, Parenteral | 3 | 1986 | 398 | 0.180 |
Why?
|
| Neuromuscular Blockade | 2 | 2018 | 146 | 0.180 |
Why?
|
| Hospital Charges | 1 | 2002 | 351 | 0.180 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 2 | 2018 | 141 | 0.180 |
Why?
|
| Analgesia | 3 | 1997 | 461 | 0.170 |
Why?
|
| Morpholines | 3 | 2007 | 581 | 0.170 |
Why?
|
| Ambulatory Care | 4 | 2014 | 2775 | 0.170 |
Why?
|
| Delayed Emergence from Anesthesia | 1 | 2018 | 10 | 0.160 |
Why?
|
| Vital Capacity | 2 | 1999 | 970 | 0.140 |
Why?
|
| Orbital Neoplasms | 1 | 1998 | 223 | 0.130 |
Why?
|
| Acetaminophen | 1 | 2020 | 554 | 0.130 |
Why?
|
| Granisetron | 2 | 2005 | 7 | 0.130 |
Why?
|
| Rhabdomyosarcoma | 1 | 1998 | 358 | 0.130 |
Why?
|
| Patient Satisfaction | 3 | 1998 | 3460 | 0.120 |
Why?
|
| Laparoscopy | 3 | 1997 | 2035 | 0.110 |
Why?
|
| Fluid Therapy | 2 | 1990 | 581 | 0.110 |
Why?
|
| Ibuprofen | 1 | 2015 | 229 | 0.110 |
Why?
|
| Double-Blind Method | 12 | 2015 | 12329 | 0.110 |
Why?
|
| Rheology | 4 | 1996 | 348 | 0.100 |
Why?
|
| Fentanyl | 3 | 1991 | 435 | 0.100 |
Why?
|
| Scopolamine | 1 | 2012 | 93 | 0.100 |
Why?
|
| Genital Diseases, Female | 2 | 1990 | 192 | 0.100 |
Why?
|
| Quality Assurance, Health Care | 2 | 2014 | 2170 | 0.100 |
Why?
|
| Postoperative Care | 1 | 1998 | 1471 | 0.100 |
Why?
|
| Muscarinic Antagonists | 1 | 2012 | 135 | 0.100 |
Why?
|
| Butorphanol | 1 | 1991 | 10 | 0.100 |
Why?
|
| Feedback | 1 | 2015 | 791 | 0.090 |
Why?
|
| Anesthetics | 2 | 2015 | 523 | 0.090 |
Why?
|
| Appointments and Schedules | 1 | 2015 | 443 | 0.090 |
Why?
|
| Humans | 64 | 2021 | 761326 | 0.090 |
Why?
|
| Anesthetics, Local | 2 | 2001 | 997 | 0.090 |
Why?
|
| Obstetrics | 1 | 2017 | 665 | 0.090 |
Why?
|
| Hysterectomy | 2 | 2005 | 857 | 0.090 |
Why?
|
| Efficiency, Organizational | 1 | 2015 | 695 | 0.090 |
Why?
|
| Drug Costs | 2 | 2015 | 1183 | 0.090 |
Why?
|
| Potassium | 1 | 2014 | 1311 | 0.080 |
Why?
|
| Receptors, GABA-A | 1 | 1993 | 623 | 0.080 |
Why?
|
| Medical Audit | 1 | 2010 | 453 | 0.080 |
Why?
|
| Spinal Canal | 1 | 1988 | 41 | 0.080 |
Why?
|
| Pain Measurement | 3 | 2015 | 3552 | 0.080 |
Why?
|
| Pressure | 3 | 1986 | 1155 | 0.070 |
Why?
|
| Analysis of Variance | 4 | 2001 | 6231 | 0.070 |
Why?
|
| Air | 1 | 1988 | 186 | 0.070 |
Why?
|
| Benzodiazepines | 1 | 1993 | 1132 | 0.070 |
Why?
|
| Adult | 32 | 2018 | 221122 | 0.070 |
Why?
|
| Epidural Space | 1 | 1988 | 122 | 0.070 |
Why?
|
| Anesthesia, Local | 2 | 2001 | 277 | 0.070 |
Why?
|
| Premedication | 1 | 1987 | 247 | 0.070 |
Why?
|
| Wounds and Injuries | 2 | 2017 | 2490 | 0.070 |
Why?
|
| Surgical Procedures, Operative | 1 | 2017 | 1923 | 0.060 |
Why?
|
| Nitrous Oxide | 2 | 1996 | 166 | 0.060 |
Why?
|
| Adjuvants, Anesthesia | 1 | 1985 | 58 | 0.060 |
Why?
|
| Central Venous Pressure | 1 | 1985 | 79 | 0.060 |
Why?
|
| Placebos | 2 | 2000 | 1667 | 0.060 |
Why?
|
| Hydrostatic Pressure | 1 | 1985 | 98 | 0.060 |
Why?
|
| Safety | 2 | 2000 | 1150 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 2273 | 0.060 |
Why?
|
| Amnesia | 1 | 1987 | 255 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 2760 | 0.060 |
Why?
|
| Drug Interactions | 3 | 1999 | 1415 | 0.060 |
Why?
|
| Catheters, Indwelling | 1 | 1986 | 427 | 0.060 |
Why?
|
| Documentation | 1 | 2010 | 897 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2000 | 3419 | 0.050 |
Why?
|
| Manometry | 1 | 1985 | 454 | 0.050 |
Why?
|
| Time Factors | 8 | 2016 | 39974 | 0.050 |
Why?
|
| Nausea | 3 | 1996 | 679 | 0.050 |
Why?
|
| Injections, Intravenous | 2 | 2005 | 1379 | 0.050 |
Why?
|
| Sex Factors | 3 | 2018 | 10551 | 0.050 |
Why?
|
| Abdomen | 1 | 2007 | 1128 | 0.050 |
Why?
|
| Female | 28 | 2018 | 392485 | 0.040 |
Why?
|
| Sleep Stages | 2 | 1996 | 693 | 0.040 |
Why?
|
| Preanesthetic Medication | 3 | 1990 | 48 | 0.040 |
Why?
|
| Anesthesiology | 1 | 2010 | 1117 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 5439 | 0.040 |
Why?
|
| Psychomotor Performance | 2 | 1999 | 1879 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2015 | 3800 | 0.040 |
Why?
|
| Neurons, Afferent | 1 | 2001 | 498 | 0.040 |
Why?
|
| Neostigmine | 1 | 2018 | 68 | 0.040 |
Why?
|
| Logistic Models | 3 | 2012 | 13251 | 0.040 |
Why?
|
| Lidocaine | 1 | 2001 | 538 | 0.040 |
Why?
|
| Headache | 2 | 2000 | 1256 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2007 | 10764 | 0.040 |
Why?
|
| Bradycardia | 1 | 2000 | 299 | 0.040 |
Why?
|
| Sciatic Nerve | 1 | 2001 | 616 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2005 | 1946 | 0.040 |
Why?
|
| Male | 21 | 2018 | 360621 | 0.040 |
Why?
|
| Middle Aged | 18 | 2018 | 220774 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2004 | 1385 | 0.040 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2018 | 241 | 0.030 |
Why?
|
| Residual Volume | 1 | 1996 | 41 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2001 | 869 | 0.030 |
Why?
|
| Anesthesia, Intravenous | 1 | 1997 | 129 | 0.030 |
Why?
|
| Health Personnel | 1 | 2010 | 3335 | 0.030 |
Why?
|
| Inhalation | 1 | 1996 | 143 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2000 | 766 | 0.030 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 1996 | 101 | 0.030 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2001 | 952 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 1 | 1996 | 361 | 0.030 |
Why?
|
| Receptors, Opioid | 1 | 1996 | 145 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2007 | 3905 | 0.030 |
Why?
|
| Cough | 1 | 1999 | 594 | 0.030 |
Why?
|
| Flatulence | 1 | 2015 | 19 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1998 | 20555 | 0.030 |
Why?
|
| Time Management | 1 | 2015 | 52 | 0.030 |
Why?
|
| United States | 4 | 2018 | 72317 | 0.030 |
Why?
|
| Capacity Building | 1 | 2017 | 258 | 0.030 |
Why?
|
| Half-Life | 1 | 1996 | 652 | 0.030 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 2014 | 43 | 0.030 |
Why?
|
| Aged, 80 and over | 6 | 2018 | 58946 | 0.030 |
Why?
|
| Anesthetics, General | 1 | 1995 | 151 | 0.030 |
Why?
|
| Remission Induction | 1 | 2000 | 2395 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2000 | 39108 | 0.030 |
Why?
|
| Gadolinium | 1 | 1998 | 960 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 2 | 1997 | 5492 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 1998 | 908 | 0.030 |
Why?
|
| Aged | 12 | 2018 | 169179 | 0.030 |
Why?
|
| Resuscitation | 2 | 1990 | 673 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2016 | 1571 | 0.030 |
Why?
|
| Goals | 1 | 2017 | 711 | 0.020 |
Why?
|
| Veins | 1 | 1996 | 768 | 0.020 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2015 | 495 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1998 | 36430 | 0.020 |
Why?
|
| Pharyngitis | 1 | 1992 | 219 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2015 | 765 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2012 | 713 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 1995 | 1668 | 0.020 |
Why?
|
| Dizziness | 1 | 1992 | 259 | 0.020 |
Why?
|
| Respiration | 1 | 1996 | 1657 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2012 | 6309 | 0.020 |
Why?
|
| Vomiting | 1 | 1992 | 652 | 0.020 |
Why?
|
| Workload | 1 | 2015 | 844 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2015 | 1188 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 1999 | 10203 | 0.020 |
Why?
|
| Risk Factors | 6 | 2018 | 74152 | 0.020 |
Why?
|
| ROC Curve | 2 | 2012 | 3572 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 2016 | 1329 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2012 | 962 | 0.020 |
Why?
|
| Nalbuphine | 1 | 1987 | 20 | 0.020 |
Why?
|
| Morphinans | 1 | 1987 | 27 | 0.020 |
Why?
|
| Image Enhancement | 1 | 1998 | 2884 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2015 | 2696 | 0.020 |
Why?
|
| Adolescent | 5 | 2016 | 88305 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2000 | 10075 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 4850 | 0.020 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2007 | 134 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2000 | 6382 | 0.020 |
Why?
|
| Injections, Epidural | 1 | 1988 | 201 | 0.020 |
Why?
|
| Blood Pressure | 2 | 1996 | 8485 | 0.020 |
Why?
|
| Pancuronium | 1 | 1985 | 43 | 0.020 |
Why?
|
| Droperidol | 1 | 1985 | 21 | 0.020 |
Why?
|
| Child | 5 | 2007 | 80156 | 0.020 |
Why?
|
| Disposable Equipment | 1 | 1985 | 46 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2018 | 54405 | 0.020 |
Why?
|
| Magnesium Sulfate | 1 | 1985 | 73 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 2 | 1985 | 1626 | 0.020 |
Why?
|
| Contrast Media | 1 | 1998 | 5310 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2000 | 12450 | 0.020 |
Why?
|
| Mathematics | 1 | 1986 | 707 | 0.020 |
Why?
|
| Diazepam | 1 | 1985 | 215 | 0.010 |
Why?
|
| Oxygen | 1 | 1996 | 4227 | 0.010 |
Why?
|
| Embolism, Air | 1 | 1985 | 110 | 0.010 |
Why?
|
| Oximetry | 1 | 1987 | 460 | 0.010 |
Why?
|
| Isotonic Solutions | 1 | 1984 | 117 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1990 | 2358 | 0.010 |
Why?
|
| Reference Standards | 1 | 1987 | 1004 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1998 | 12972 | 0.010 |
Why?
|
| Neuromuscular Junction | 1 | 1985 | 403 | 0.010 |
Why?
|
| Anti-Anxiety Agents | 1 | 1985 | 397 | 0.010 |
Why?
|
| Infusion Pumps | 2 | 1996 | 163 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2007 | 64645 | 0.010 |
Why?
|
| Decision Making | 1 | 1995 | 3929 | 0.010 |
Why?
|
| Spinal Nerve Roots | 1 | 2001 | 121 | 0.010 |
Why?
|
| Young Adult | 2 | 2018 | 59196 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2018 | 12949 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1987 | 1165 | 0.010 |
Why?
|
| Neural Conduction | 1 | 2001 | 441 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 21336 | 0.010 |
Why?
|
| Linear Models | 1 | 1990 | 5871 | 0.010 |
Why?
|
| Boston | 1 | 1992 | 9333 | 0.010 |
Why?
|
| Intercostal Muscles | 1 | 1979 | 26 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2012 | 3438 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2001 | 1262 | 0.010 |
Why?
|
| Breathing Exercises | 1 | 1979 | 59 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1985 | 1780 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 1984 | 1299 | 0.010 |
Why?
|
| Diaphragm | 1 | 1979 | 351 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1988 | 3577 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2001 | 1735 | 0.010 |
Why?
|
| Infant | 1 | 1998 | 36202 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1998 | 42251 | 0.010 |
Why?
|
| Mental Recall | 1 | 2001 | 1214 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2001 | 1878 | 0.010 |
Why?
|
| Axons | 1 | 2001 | 1674 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 8632 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2003 | 3687 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 8166 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1992 | 15647 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 15835 | 0.010 |
Why?
|
| Computers | 1 | 1990 | 596 | 0.000 |
Why?
|
| Dreams | 1 | 1987 | 146 | 0.000 |
Why?
|
| Vecuronium Bromide | 1 | 1985 | 33 | 0.000 |
Why?
|
| Rats | 1 | 2001 | 23729 | 0.000 |
Why?
|
| Random Allocation | 1 | 1987 | 2389 | 0.000 |
Why?
|
| Magnesium | 1 | 1985 | 809 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2003 | 23981 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1996 | 14665 | 0.000 |
Why?
|
| Length of Stay | 1 | 1987 | 6422 | 0.000 |
Why?
|
| Software | 1 | 1987 | 4439 | 0.000 |
Why?
|
| Anxiety | 1 | 1987 | 4571 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1987 | 7999 | 0.000 |
Why?
|
| Animals | 1 | 2001 | 168388 | 0.000 |
Why?
|